Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

PRINCETON, NJ, USA I July 15, 2025 I Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company developing first-in-class medicines based on ...

In postmenopausal women with overweight or obesity receiving tirzepatide, use of MHT is associated with superior weight loss outcomes.

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

WEIGHT loss jabs are changing people’s lives. For the 1.5 million Brits already on them, many are likely to be shedding the pounds, and fast. While new studies suggest they may make people ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...